Skip to main content

Table 1 Characteristics of the sustained period of “getting to zero” VAP prevention program in the ICU

From: A program for sustained improvement in preventing ventilator associated pneumonia in an intensive care setting

  2009 2010
Patient-days (total) 10,889 11,095
Number of patients 2,705 2,717
Age, mean ± SD (in years) 67±19 66±18
Male, n (%) 1,571 (58.1%) 1,587 (58.4%)
APACHE, mean ± SD 18±6 18±7
Ventilator-days (total) 3,009 3,043
Ventilator utilization ratio 0.28 0.27
MV days – median (IQR) 4 (1–22) 3.7 (1–23)
Ventilator-free days 7,880 8,052
ICU LOS days – mean ± SD 3.9±0.4 4.0±0.3
Compliance with process measures, n (%)
HOB observations 2362/2396 (98.6%) 2260/2486 (90.9%)
Daily “sedation interruptions” 2358/2396 (98.4%) 2273/2486 (91.4%)
Gastric prophylaxis 2393/2396 (99.9%) 2276/2486 (91.5%)
DVT/PE prevention 2363/2396 (98.6%) 2266/2486 (91.1%)
Ventilator circuits without changes 610/611 (99.8%) 387/390 (99.2%)
HMEs changed 584/611 (95.5%) 368/390 (94.3%)
Ventilator-circuit-tubing condensate 564/611 (92.3%) 360/390 (92.3%)
CASS endotracheal tube - n 342 311
Number of VAPs 4 6
Number of VATs 3 6
VAP rate per 1,000 ventilator-days 1.3 2.0
VAT rate per 1,000 ventilator-days 1.0 2.0
In-hospital mortality in VAP patients, n (%) 4/4 (100) 5/6 (83)
In-hospital mortality in ICU patients, n 196 220
In-hospital mortality in ICU patients per 10,000 patient days 180 198
  1. CASS Continuous Aspiration of Subglottic Secretions.
  2. DVT/PE Deep Venous Thrombosis/Pulmonary Embolism.
  3. ICU LOS Intensive Care – Length of Stay.
  4. HMEs Heat-and-Moisture Exchanges.
  5. HOB Head of the Bed.
  6. MV Mechanical Ventilation.
  7. SD Standard Deviation.
  8. VAP Ventilator Associated Pneumonia.
  9. VAT Ventilator Associated Tracheobronchitis.